DARU Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial. 口服骨化三醇对自体干细胞移植后造血恢复和存活的影响:一项随机临床试验。
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-12-01 Epub Date: 2019-11-11 DOI: 10.1007/s40199-019-00306-y
Kosar Raoufinejad, Ahmad Reza Shamshiri, Shahrzad Pezeshki, Bahram Chahardouli, Molouk Hadjibabaie, Zahra Jahangard-Rafsanjani, Kheirollah Gholami, Mehdi Rajabi, Mohammad Vaezi
{"title":"Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial.","authors":"Kosar Raoufinejad,&nbsp;Ahmad Reza Shamshiri,&nbsp;Shahrzad Pezeshki,&nbsp;Bahram Chahardouli,&nbsp;Molouk Hadjibabaie,&nbsp;Zahra Jahangard-Rafsanjani,&nbsp;Kheirollah Gholami,&nbsp;Mehdi Rajabi,&nbsp;Mohammad Vaezi","doi":"10.1007/s40199-019-00306-y","DOIUrl":"https://doi.org/10.1007/s40199-019-00306-y","url":null,"abstract":"<p><strong>Background: </strong>Calcitriol, the active metabolite of vitamin D, is an essential regulator in the hematopoiesis and immunity. However, knowledge revealing its influence on the immune and hematologic reconstitution after hematopoietic stem cell transplantation (HSCT) in clinical trials is very limited.</p><p><strong>Objectives: </strong>The effects of calcitriol on short-term and long-term hematopoietic recovery, relapse-free survival (RFS) and overall survival (OS) in multiple myeloma, Hodgkin's and non-Hodgkin's lymphoma following autologous peripheral blood HSCT were assessed.</p><p><strong>Methods: </strong>Eighty patients (age: 18-68 years) in complete remission were allocated 1:1 to two groups by balanced block randomization. Calcitriol 0.25 μg or placebo capsule was administered three times daily from transplantation to day 30. Absolute neutrophil count (ANC), absolute lymphocyte count (ALC), and platelet count (PC) were determined daily from transplantation to day 30. White blood cell count (WBC), PC, and hemoglobin concentration (HC) of days 180 and 365 were extracted from clinic files. A thorough examination for oral mucositis (OM) was completed daily during hospital stay. Adverse drug reactions (ADRs) as well as two-year RFS and OS were evaluated.</p><p><strong>Results: </strong>Median time to ANC engraftment (≥0.5 × 10<sup>3</sup>/μl: 10.0 vs. 11.0 days; P = 0.98) and PC engraftment (≥20.0 × 10<sup>3</sup>/μl: both 14.0 days; P = 0.58) was similar between groups. However, the median time to ALC recovery was significantly shorter in the calcitriol group (≥0.5 × 10<sup>3</sup>/μl: 13.0 vs. 20.0 days; P < 0.001). Moreover, ALC recovery rates on day 15 (≥0.5 × 10<sup>3</sup>/μl: 82.1% vs. 42.5%; P < 0.001) and on day 30 (≥1.0 × 10<sup>3</sup>/μl: 91.7% vs. 57.5%; P = 0.001) was significantly higher with calcitriol. WBC, PC, and HC on days 180 and 365 were not significantly different between groups. None of the OM indices were modulated by calcitriol. All the ADRs were non-serious and mild, possibly or unlikely related to the intervention. In a median of 29 months follow-up, RFS was significantly better in the calcitriol group (77.0%, SE = 7.0% vs. 59.0%, SE = 8.0%; P = 0.03), albeit the OS was not affected (87.0%, SE = 5.0% vs. 92.0%, SE = 4.0%; P = 0.72).</p><p><strong>Conclusion: </strong>Calcitriol could improve ALC recovery and RFS as a safe option post-HSCT. Graphical abstract Oral calcitriol 0.25 µg three times daily from transplantation to day 30 improved lymphocytes recovery and two-year relapse-free survival as a safe option in 80 patients of autologous hematopoietic stem cell transplantation in comparison with placebo.</p>","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"27 2","pages":"709-720"},"PeriodicalIF":3.6,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40199-019-00306-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49675388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Application of computational tools for the designing of Oleuropein loaded nanostructured lipid carrier for brain targeting through nasal route 计算工具在橄榄苦苷纳米结构脂质载体鼻腔脑靶向设计中的应用
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-25 DOI: 10.1007/s40199-019-00304-0
Sucharitha Palagati, Satyanarayana Sv, B. Kesavan
{"title":"Application of computational tools for the designing of Oleuropein loaded nanostructured lipid carrier for brain targeting through nasal route","authors":"Sucharitha Palagati, Satyanarayana Sv, B. Kesavan","doi":"10.1007/s40199-019-00304-0","DOIUrl":"https://doi.org/10.1007/s40199-019-00304-0","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"133 1","pages":"695 - 708"},"PeriodicalIF":3.6,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73778443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy 双硫仑给药的最新进展:对改善其药代动力学特征和抗癌功效的有前途的方法的关键分析
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-22 DOI: 10.1007/s40199-019-00308-w
M. Farooq, M. Aquib, Daulat Haleem Khan, Z. Hussain, Anam Ahsan, M. Baig, D. Wande, Muhammad Masood Ahmad, H. Ahsan, Jiang Jiajie, Bo Wang
{"title":"Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy","authors":"M. Farooq, M. Aquib, Daulat Haleem Khan, Z. Hussain, Anam Ahsan, M. Baig, D. Wande, Muhammad Masood Ahmad, H. Ahsan, Jiang Jiajie, Bo Wang","doi":"10.1007/s40199-019-00308-w","DOIUrl":"https://doi.org/10.1007/s40199-019-00308-w","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"124 1","pages":"853 - 862"},"PeriodicalIF":3.6,"publicationDate":"2019-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79494157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS) 中药治疗多囊卵巢综合征(PCOS)临床研究综述
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-18 DOI: 10.1007/s40199-019-00312-0
A. Moini Jazani, Hamidreza Nasimi Doost Azgomi, Alireza Nasimi Doost Azgomi, R. Nasimi Doost Azgomi
{"title":"A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)","authors":"A. Moini Jazani, Hamidreza Nasimi Doost Azgomi, Alireza Nasimi Doost Azgomi, R. Nasimi Doost Azgomi","doi":"10.1007/s40199-019-00312-0","DOIUrl":"https://doi.org/10.1007/s40199-019-00312-0","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"78 2 1","pages":"863 - 877"},"PeriodicalIF":3.6,"publicationDate":"2019-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77417869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 68
Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats 鞣花酸通过上调Nrf2表达和抑制IĸBα/NFĸB减少甲氨蝶呤诱导的大鼠细胞凋亡和线粒体功能障碍
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-18 DOI: 10.1007/s40199-019-00309-9
R. Ebrahimi, M. Sepand, S. Seyednejad, A. Omidi, Mostafa Akbariani, M. Gholami, O. Sabzevari
{"title":"Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats","authors":"R. Ebrahimi, M. Sepand, S. Seyednejad, A. Omidi, Mostafa Akbariani, M. Gholami, O. Sabzevari","doi":"10.1007/s40199-019-00309-9","DOIUrl":"https://doi.org/10.1007/s40199-019-00309-9","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"33 1","pages":"721 - 733"},"PeriodicalIF":3.6,"publicationDate":"2019-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77048825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 55
Traditional, complementary and alternative medicine in children constipation: a systematic review 儿童便秘的传统、补充和替代医学:系统综述
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-16 DOI: 10.1007/s40199-019-00297-w
Maryam Sadat Paknejad, Monireh Sadat Motaharifard, Shahdis Barimani, Payam Kabiri, M. Karimi
{"title":"Traditional, complementary and alternative medicine in children constipation: a systematic review","authors":"Maryam Sadat Paknejad, Monireh Sadat Motaharifard, Shahdis Barimani, Payam Kabiri, M. Karimi","doi":"10.1007/s40199-019-00297-w","DOIUrl":"https://doi.org/10.1007/s40199-019-00297-w","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"50 20","pages":"811 - 826"},"PeriodicalIF":3.6,"publicationDate":"2019-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40199-019-00297-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72489081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis 超顺磁负载别嘌呤醇壳聚糖包覆纳米颗粒靶向肾脏治疗高尿酸血症性肾结石
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-05 DOI: 10.1007/s40199-019-00300-4
Gurpreet Kandav, D. Bhatt, D. Jindal
{"title":"Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis","authors":"Gurpreet Kandav, D. Bhatt, D. Jindal","doi":"10.1007/s40199-019-00300-4","DOIUrl":"https://doi.org/10.1007/s40199-019-00300-4","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"56 1","pages":"661 - 671"},"PeriodicalIF":3.6,"publicationDate":"2019-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90435518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials 补充益生菌对2型糖尿病患者葡萄糖和氧化应激的影响:一项随机试验的荟萃分析
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-11-05 DOI: 10.1007/s40199-019-00302-2
Edris Ardeshirlarijani, Ozra Tabatabaei-Malazy, S. Mohseni, M. Qorbani, B. Larijani, R. Baradar Jalili
{"title":"Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials","authors":"Edris Ardeshirlarijani, Ozra Tabatabaei-Malazy, S. Mohseni, M. Qorbani, B. Larijani, R. Baradar Jalili","doi":"10.1007/s40199-019-00302-2","DOIUrl":"https://doi.org/10.1007/s40199-019-00302-2","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"5 1","pages":"827 - 837"},"PeriodicalIF":3.6,"publicationDate":"2019-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87663599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 66
Cellulose nanofibers from lignocellulosic biomass of lemongrass using enzymatic hydrolysis: characterization and cytotoxicity assessment. 利用酶水解从柠檬草木质纤维素生物质中提取纤维素纳米纤维:表征和细胞毒性评估。
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-10-25 DOI: 10.1007/s40199-019-00303-1
P. Kumari, Gauri Pathak, Ruby Gupta, D. Sharma, A. Meena
{"title":"Cellulose nanofibers from lignocellulosic biomass of lemongrass using enzymatic hydrolysis: characterization and cytotoxicity assessment.","authors":"P. Kumari, Gauri Pathak, Ruby Gupta, D. Sharma, A. Meena","doi":"10.1007/s40199-019-00303-1","DOIUrl":"https://doi.org/10.1007/s40199-019-00303-1","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"24 1","pages":"683 - 693"},"PeriodicalIF":3.6,"publicationDate":"2019-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81825327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Improved activity and expression of recombinant human factor IX by propeptide engineering 通过前肽工程提高重组人因子IX的活性和表达
IF 3.6 4区 医学
DARU Journal of Pharmaceutical Sciences Pub Date : 2019-10-21 DOI: 10.1007/s40199-019-00299-8
J. Vatandoost, M. Bos
{"title":"Improved activity and expression of recombinant human factor IX by propeptide engineering","authors":"J. Vatandoost, M. Bos","doi":"10.1007/s40199-019-00299-8","DOIUrl":"https://doi.org/10.1007/s40199-019-00299-8","url":null,"abstract":"","PeriodicalId":10888,"journal":{"name":"DARU Journal of Pharmaceutical Sciences","volume":"1 1","pages":"653 - 660"},"PeriodicalIF":3.6,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83739025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信